Showing results (91-100 of 123) with videos related to
Sort By:
Pageof 13
Biorxiv : the Preprint Server for Biology|September 30, 2024
Overcoming immune evasion from post-translational modification of a mutant KRAS epitope to achieve TCR-T cell-mediated antitumor activityJihoon William Lee, Emily Y Chen, Taylor Hu, et al.AIDS (London, England)|September 21, 2000
Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapyP A Bart, G P Rizzardi, G Tambussi, et al.Cancer Immunology Research|March 18, 2020
Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8+ T Cells within Polyomavirus-Driven Merkel Cell CarcinomasLichen Jing, Mariliis Ott, Candice D Church, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2016
T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor RegressionAude G Chapuis, Ilana M Roberts, John A Thompson, et al.Cancer Immunology Research|January 17, 2014
Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-IAude G Chapuis, Olga K Afanasiev, Jayasri G Iyer, et al.Science Translational Medicine|March 1, 2013
Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patientsAude G Chapuis, Gunnar B Ragnarsson, Hieu N Nguyen, et al.JCI Insight|May 8, 2024
MR1-restricted T cell clonotypes are associated with "resistance" to Mycobacterium tuberculosis infectionDeborah L Cross, Erik D Layton, Krystle Kq Yu, et al.Journal for Immunotherapy of Cancer|February 4, 2026
Dysregulated expression of the tumor suppressor p14ARF in cancer provides an effective target for TCR-T cell therapeuticsThomas M Schmitt, Kelsey Furiya, Cheryl Black, et al.Nature Biomedical Engineering|October 22, 2025
Collagen-binding IL-12-armoured STEAP1 CAR-T cells reduce toxicity and treat prostate cancer in mouse modelsKoichi Sasaki, Vipul Bhatia, Yuta Asano, et al.Medrxiv : the Preprint Server for Health Sciences|February 14, 2024
Expansion of the HSV-2-specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccineEmily S Ford, Alvason Li, Kerry J Laing, et al.Pageof 13